InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Relay Therapeutics, Inc.

RLAY Clue Score52
United States Fiscal year ends December CIK 0001812364 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

39
Insider
Date
Role
Action
Shares
Price
Amount
Thomas Catinazzo
28 Oct 2026
Chief Financial Officer
Sell
1,469
$18.62
$27.35K
Donald A Bergstrom
28 Oct 2026
President, R&D
Sell
2,252
$18.62
$41.93K
Peter Rahmer
28 Oct 2026
See remarks
Sell
753
$18.62
$14.02K
Sanjiv Patel
7 Oct 2026
President and CEO
Sold on a plan
48,199
$18.10
$872.40K
Thomas Catinazzo
6 Oct 2026
Chief Financial Officer
Sold on a plan
206
$19.26
$3.97K
Thomas Catinazzo
6 Oct 2026
Chief Financial Officer
Sold on a plan
17,511
$18.58
$325.35K
Sanjiv Patel
8 Sep 2026
President and CEO
Sold on a plan
48,199
$18.94
$912.89K
Thomas Catinazzo
8 Sep 2026
Chief Financial Officer
Sold on a plan
17,717
$18.94
$335.56K
Donald A Bergstrom
8 Sep 2026
President, R&D
Sold on a plan
8,530
$18.97
$161.81K
Peter Rahmer
26 Aug 2026
See remarks
Sold on a plan
4,508
$20.03
$90.30K
SVF Pauling (Cayman) Ltd
25 Aug 2026
10% owner
Sell indirect
6,000,000
$19.40
$116.40M
Sanjiv Patel
17 Aug 2026
President and CEO
Sold on a plan
48,199
$20.33
$979.89K
Thomas Catinazzo
14 Aug 2026
Chief Financial Officer
Sold on a plan
17,717
$19.74
$349.73K
Donald A Bergstrom
28 Jul 2026
President, R&D
Sell
2,237
$18.61
$41.63K
Peter Rahmer
28 Jul 2026
See remarks
Sell
748
$18.61
$13.92K
Thomas Catinazzo
28 Jul 2026
Chief Financial Officer
Sell
1,459
$18.61
$27.15K
Sanjiv Patel
7 Jul 2026
President and CEO
Sold on a plan
48,199
$19.58
$943.74K
Thomas Catinazzo
6 Jul 2026
Chief Financial Officer
Sold on a plan
17,717
$18.69
$331.13K
Donald A Bergstrom
6 Jul 2026
President, R&D
Sold on a plan
8,660
$18.71
$162.03K
Peter Rahmer
30 Jun 2026
See remarks
Sold on a plan
50,000
$19.09
$954.50K
Donald A Bergstrom
22 Jun 2026
President, R&D
Sold after exercise
93,456
$16.94
$1.58M
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
51,560
$16.97
$874.97K
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
61,563
$16.97
$1.04M
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
56,323
$16.97
$955.80K
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
17,717
$17.01
$301.37K
Thomas Catinazzo
14 May 2026
Chief Financial Officer
Sold on a plan
17,717
$12.86
$227.84K
Donald A Bergstrom
28 Apr 2026
President, R&D
Sell
1,490
$14.79
$22.04K
Peter Rahmer
28 Apr 2026
See remarks
Sell
753
$14.79
$11.14K
Thomas Catinazzo
28 Apr 2026
Chief Financial Officer
Sell
972
$14.79
$14.38K
Thomas Catinazzo
9 Apr 2026
Chief Financial Officer
Sold after exercise
1,800
$15.00
$27.00K
Thomas Catinazzo
7 Apr 2026
Chief Financial Officer
Sold on a plan
17,717
$13.01
$230.50K
Thomas Catinazzo
9 Mar 2026
Chief Financial Officer
Sold on a plan
17,717
$10.06
$178.23K
Thomas Catinazzo
28 Jan 2026
Chief Financial Officer
Sell
1,695
$8.45
$14.32K
Peter Rahmer
28 Jan 2026
See remarks
Sell
1,354
$8.45
$11.44K
Donald A Bergstrom
28 Jan 2026
President, R&D
Sell
2,686
$8.45
$22.70K
Thomas Catinazzo
27 Jan 2026
Chief Financial Officer
Sell
13,820
$7.62
$105.31K
Peter Rahmer
27 Jan 2026
See remarks
Sell
11,684
$7.62
$89.03K
Donald A Bergstrom
27 Jan 2026
President, R&D
Sell
18,895
$7.62
$143.98K
Sanjiv Patel
6 Jan 2026
President and CEO
Sell
43,168
$7.82
$337.57K

What was left out

Form 4 filings counted 44
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 6
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 272,802
History held since 20 Jul 2020